Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.


Journal

Cancer prevention research (Philadelphia, Pa.)
ISSN: 1940-6215
Titre abrégé: Cancer Prev Res (Phila)
Pays: United States
ID NLM: 101479409

Informations de publication

Date de publication:
03 2019
Historique:
received: 30 10 2018
revised: 10 01 2019
accepted: 11 01 2019
pubmed: 18 1 2019
medline: 10 6 2020
entrez: 18 1 2019
Statut: ppublish

Résumé

Most cervical cancers occur in women who do not participate in cervical-cancer screening. We therefore evaluated adherence to screening for clinic-based Pap testing, self-collected sampling for HPV testing, and choice of the 2 among 483 unscreened/underscreened women in Brazil. Three public Basic Health Units (BHU) were each randomly assigned to three arms: (i) Pap testing at the BHU (

Identifiants

pubmed: 30651294
pii: 1940-6207.CAPR-18-0419
doi: 10.1158/1940-6207.CAPR-18-0419
pmc: PMC7285814
mid: NIHMS1519131
doi:

Banques de données

ClinicalTrials.gov
['NCT03713697']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-170

Subventions

Organisme : NCI NIH HHS
ID : P30 CA013148
Pays : United States

Informations de copyright

©2019 American Association for Cancer Research.

Références

Int J STD AIDS. 2010 Feb;21(2):105-9
pubmed: 20089995
Health Promot Int. 2019 Feb 1;34(1):95-101
pubmed: 29036489
J Health Care Poor Underserved. 2016;27(4):1779-1793
pubmed: 27818438
BMC Public Health. 2014 Jun 12;14:596
pubmed: 24927941
Cancer. 2013 Apr 1;119(7):1365-72
pubmed: 23280399
Am J Clin Oncol. 2018 Mar;41(3):289-294
pubmed: 26808257
Cancer Causes Control. 2006 Apr;17(3):299-306
pubmed: 16489537
Arch Gynecol Obstet. 2013 Jan;287(1):53-8
pubmed: 22886356
Am J Epidemiol. 1978 Aug;108(2):100-2
pubmed: 707470
JAMA. 2002 Apr 24;287(16):2114-9
pubmed: 11966386
Arch Pathol Lab Med. 2004 Nov;128(11):1224-9
pubmed: 15504056
BMJ. 2018 Dec 5;363:k4823
pubmed: 30518635
Prev Med. 2007 Aug-Sep;45(2-3):93-106
pubmed: 17651792
Health Promot Pract. 2012 Jan;13(1):29-40
pubmed: 21422254
Arch Pathol Lab Med. 2015 Mar;139(3):373-7
pubmed: 25724034
PLoS One. 2015 Sep 02;10(9):e0137299
pubmed: 26332236
Int J Gynecol Pathol. 2011 Mar;30(2):173-84
pubmed: 21293281
Ethn Dis. 2018 Feb 1;28(1):11-18
pubmed: 29467561
J Clin Epidemiol. 1996 Apr;49(4):435-9
pubmed: 8621994
Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):717-20
pubmed: 18349293
J Natl Cancer Inst. 2005 May 4;97(9):675-83
pubmed: 15870438
Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1398-1406
pubmed: 30185535
J Rural Health. 2014 Spring;30(2):196-205
pubmed: 24689544
BMC Cancer. 2018 Feb 2;18(1):126
pubmed: 29394915
Stat Med. 1985 Jan-Mar;4(1):87-90
pubmed: 3992076
Prog Community Health Partnersh. 2018;12(1S):111-119
pubmed: 29755054
Lancet. 2011 Nov 26;378(9806):1868-73
pubmed: 22051739
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):835-43
pubmed: 21430302
Sao Paulo Med J. 2014;132(1):3-9
pubmed: 24474073
Int J Gynecol Cancer. 2006 May-Jun;16(3):955-62
pubmed: 16803469
J Low Genit Tract Dis. 2013 Jan;17(1):38-47
pubmed: 22885643
Int J Gynaecol Obstet. 2014 Aug;126(2):156-60
pubmed: 24880188
Gynecol Oncol. 2009 Aug;114(2):365-9
pubmed: 19464729
Cancer Cytopathol. 2016 Aug;124(8):581-8
pubmed: 27070446
J Gen Intern Med. 2018 Jul;33(7):1077-1083
pubmed: 29594933
Braz J Infect Dis. 2006 Oct;10(5):331-6
pubmed: 17293921
J Glob Oncol. 2016 Oct 12;3(5):635-657
pubmed: 29094101
Lancet Oncol. 2011 Sep;12(9):880-90
pubmed: 21865084
J Glob Oncol. 2017 Jan 18;3(5):444-454
pubmed: 29094082
Rev Saude Publica. 2015;49:17
pubmed: 25741655
Gynecol Oncol. 2013 Oct;131(1):131-4
pubmed: 23880151
Braz J Infect Dis. 2016 Jan-Feb;20(1):61-8
pubmed: 26706020
Rev Saude Publica. 2009 Oct;43(5):851-8
pubmed: 19768236
J Natl Cancer Inst. 2012 Feb 8;104(3):178-88
pubmed: 22271765
Lancet Glob Health. 2015 Feb;3(2):e85-94
pubmed: 25617202
Am J Epidemiol. 1994 Aug 1;140(3):279-89; discussion 300-1
pubmed: 8030631
Prev Med. 2011 Jun;52(6):452-5
pubmed: 21497619

Auteurs

Philip E Castle (PE)

Albert Einstein College of Medicine, Bronx, New York. castle.philip@gmail.com.

Vânia R S Silva (VRS)

Universidade Estadual de Maringá, Maringá, Paraná, Brazil.

Marcia E L Consolaro (MEL)

Universidade Estadual de Maringá, Maringá, Paraná, Brazil.

Nádia Kienen (N)

Universidade Estadual de Londrina, Londrina, Paraná, Brazil.

Lorna Bittencourt (L)

University of Alabama at Birmingham, Birmingham, Alabama.

Sandra M Pelloso (SM)

Universidade Estadual de Maringá, Maringá, Paraná, Brazil.

Edward E Partridge (EE)

University of Alabama at Birmingham, Birmingham, Alabama.

Amanda Pierz (A)

Albert Einstein College of Medicine, Bronx, New York.

Camila B Dartibale (CB)

Universidade Estadual de Maringá, Maringá, Paraná, Brazil.

Nelson S Uchimura (NS)

Universidade Estadual de Maringá, Maringá, Paraná, Brazil.

Isabel C Scarinci (IC)

University of Alabama at Birmingham, Birmingham, Alabama.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH